Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

ORGANON PHARMA PTY LTD

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (127)
Cancellation by sponsor (48)
Prescription medicine evaluation (1)

Date

2026 (37)
2025 (4)
2024 (1)
2023 (19)
2022 (2)
2021 (2)
2020 (1)
2019 (2)
2017 (1)
2016 (9)
2015 (9)
2014 (1)
2013 (18)
2012 (4)
2011 (2)
2010 (6)
2008 (2)
2007 (3)
2006 (5)
2005 (8)
2003 (1)
2002 (2)
2001 (5)
2000 (2)
1999 (5)
1998 (4)
1997 (4)
1996 (1)
1995 (1)
1993 (2)
1992 (3)
1991 (10)

Search

Sponsor content

176 result(s) found, displaying 51 to 60

OLMESARTAN/ AMLODIPINE HCT - DSK 40/5/25 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE HCT - DSK 20/5/12.5 olmesartan medoxomil 20mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
EZETIMIBE MSD ezetimibe 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 November 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186)

29 March 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system.
OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
PREGNYL gonadotrophin - chorionic human 1500IU powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

31 August 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.